Lisdexamfetamine Dimesylate Capsule
Product Images NDC 47781-565

This text provides information related to a special population, specifically focusing on gender, age, and renal impairment. The gender is categorized as male or female, while the age is divided into two groups: 65-74 years and 75 years and above. Renal impairment is evaluated in three categories: mild, moderate, and severe, along with end-stage renal disease. The text also mentions several measurements, such as PK, Cmax, and AUC, which seem to be recorded multiple times. Additionally, there is a mention of fold change and 90% confidence interval, followed by a change relative to a reference value of 25. Overall, this text provides some information on a special population's characteristics and measurements, possibly in the context of a study or research.*

The text provides a list of interacting drugs, including Guanfacine and Venlafaxine. It also mentions different CYP enzyme substrates such as Caffeine, Dextromethorphan, Omeprazole, and Midazolam. Additionally, the text mentions PK (possibly referring to pharmacokinetics) and AUC (possibly referring to area under the curve) values. It also refers to "Fold Change and 90% CI." Overall, the text appears to be discussing the interaction between drugs and the impact on certain enzymes and pharmacokinetic parameters.*

Not available*

Not available.*

This text appears to be the label of a medication container. The medication is lisdexamfetamine dimesylate, with each capsule containing 10 mg of the active ingredient. The capsules are distributed by Abvogen, Inc. in Morristown, NJ, USA. It is a product of the USA with the National Drug Code (NDC) 47781-562-01. The pharmacist is instructed to dispense the medication guide separately to each patient. The dosage information can be found in the package insert. The medication should be stored at room temperature between 20°C and 25°C, with excursions permitted between 15°C and 30°C. It should be dispensed in a tight, light-resistant container. The label also includes a revision date of 06/2022 and the code PKGD2963.*

Each capsule contains 20 mg of lisdexamfetamine dimesylate, equivalent to 11.6 mg of lisdexamfetamine. This medication is distributed by Alvogen, Inc in Morristown, NJ 07960, USA. It is a product of the USA and has the NDC code 47781-563-01. The package includes 100 capsules and a medication guide for each patient. The dosage information can be found in the package insert. It is recommended to store the capsules at room temperature, between 20°C and 25°C (68°F and 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F) as per USP guidelines. The medication should be dispensed in a light-resistant container as defined in the USP. The revision date of this information is 06/2022.*

Each capsule contains 40 mg of lisdexamfetamine dimesylate, which is equivalent to 23.1 mg of Tisdexametamine. It is distributed by Alvogen, Inc. in Morristown, NJ, USA. This product is a controlled substance that requires a prescription and comes in a pack of 100 capsules. The pharmacist must dispense the medication guide provided separately to each patient. The package insert should be consulted for dosage information. The capsules should be stored at room temperature, between 20°C and 25°C (68°F to 77°F), with excursions permitted between 16°C and 30°C (59°F and 86°F). It should be dispensed in a tight, light-resistant container. The NDC number for this product is 47781-565-01.*

Each capsule of this product contains 50 mg of lisdexamfetamine dimesylate, which is equivalent to 28.9 mg of lisdexamfetamine. It is distributed by Alvogen, Inc. and is a product of the USA. The National Drug Code (NDC) for this medication is 47781-566-01. Pharmacists should dispense the medication guide separately to each patient. This product is available only by prescription and comes in a package of 100 capsules. Dosage information can be found in the package insert. It should be stored at room temperature between 20°C and 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F and 86°F). The medication should be dispensed in a tightly sealed, light-resistant container as specified by the United States Pharmacopeia (USP). This package was last revised in June 2022.*

Each capsule of this product contains 60 mg of lisdexamfetamine dimesylate, which is equivalent to 34.7 mg of lisdexamfetamine. The product is distributed by Alvogen, Inc., located in Morristown, NJ 07960, USA. It is a product of the USA. The National Drug Code (NDC) for this product is 47781-567-01. It is a prescription-only medication and comes in a package of 100 capsules. The medication guide should be provided separately to each patient by the pharmacist. The dosage information can be found in the package insert. The product should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). It should be dispensed in a tight, light-resistant container as defined in the USP. The package was last revised in June 2022 and has the code PKGD29L8.*

Each Capsule contains 70 mg of lisdexamfetamine dimesylate, which is equivalent to 40.5 mg of lisdexamfetamine. This medication is distributed by Alvogen, Inc. in Morristown, NJ, USA. It is a product of the USA. The NDC number for this medication is 47781-568-01. The capsules are meant to be dispensed by a pharmacist with a Medication Guide provided separately for each patient. The recommended dosage information can be found in the package insert. The capsules should be stored at room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). They should be kept in a tight, light-resistant container as defined in the USP. This information is valid until June 2022 (Rev. 06/2022).*